FDA Grants Priority Review For Innoviva's Zoliflodacin For Treatment Of Uncomplicated Gonorrhea
12/6 13:48
(RTTNews) - Innoviva Specialty Therapeutics, Inc., a unit of Innoviva, Inc. (INVA), in partnership with the Global Antibiotic Research & Development Partnership (GARDP), Thursday said that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Ap...